NANTES, France - March 26, 2025, 6:15 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and ...
NANTES, France – March 26, 2025, 6:15 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and ...
System Center delivers a simplified datacenter management experience to keep you in control of your IT—whether on-premises, in the cloud, or across platforms. It builds on the experience and depth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback